These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11139972)

  • 1. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT.
    Gold MR; Nisam S;
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1981-5. PubMed ID: 11139972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
    Prystowsky EN; Nisam S
    Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of MADIT and MUSTT in clinical practice: results of an international survey.
    Nisam S; Henry S; Wilber DJ
    Ann Noninvasive Electrocardiol; 2002 Oct; 7(4):399-405. PubMed ID: 12431320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of nonsustained ventricular tachycardia after revascularization.
    Mittal S; Lomnitz DJ; Mirchandani S; Stein KM; Markowitz SM; Slotwiner DJ; Iwai S; Das MK; Lerman BB
    J Cardiovasc Electrophysiol; 2002 Apr; 13(4):342-6. PubMed ID: 12033350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular arrhythmias and sudden cardiac death: an insight from recent multicenter randomized clinical trials.
    Akiyama T
    Keio J Med; 1996 Dec; 45(4):313-7. PubMed ID: 9023449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator therapy in postinfarction patients.
    Zareba W
    Curr Opin Cardiol; 2004 Nov; 19(6):619-24. PubMed ID: 15502509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Fisher JD; Buxton AE; Lee KL; Packer DL; Echt DS; Denes P; Lehmann MH; DiMarco JP; Roy D; Hafley GE;
    Am J Cardiol; 2007 Jul; 100(1):76-83. PubMed ID: 17599445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AICD treatment in 2004--state of the art.
    Budde T
    Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Ellison KE; Hafley GE; Hickey K; Kellen J; Coromilas J; Stein KM; Lee KL; Buxton AE;
    Circulation; 2002 Nov; 106(21):2694-9. PubMed ID: 12438295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
    Franqui-Rivera H; Sotomonte JC
    P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MUSTT study: evaluating testing and treatment.
    Klein HU; Reek S
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():45-50. PubMed ID: 10590488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.